| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/10/17 | 05 : 44 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/09 | 20 : 33 | IH Market News | Monday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and more | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 07 : 21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 07 : 17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 07 : 08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 07 : 03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 07 : 01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 06 : 59 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 06 : 54 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 06 : 51 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 30 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 24 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 18 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 16 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 13 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 11 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 08 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/07 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/06 | 21 : 30 | Business Wire | Rule 17(e) Announcement - Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/05 | 20 : 40 | Business Wire | Rule 17(d) Announcement – Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/05 | 20 : 32 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/04 | 00 : 15 | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/04 | 00 : 06 | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/03 | 00 : 39 | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/03 | 00 : 24 | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 2023/10/02 | 21 : 00 | Business Wire | Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |